VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) announced that it has filed and obtained a receipt for a preliminary multijurisdictional short form base shelf prospectus with… Read More
VICTORIA, BC – StarFish Medical, a premier medical device design and manufacturing company, will exhibit in booth 1794 at MD&M West 2024, February 6-8, 2024 at the Anaheim Convention Center in… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) is deeply concerned with the U.S. Food and Drug Administration’s (FDA) decision to allow Florida to import drugs from Canada. “Canada simply can’t supply… Read More
Preliminary unaudited total net revenue for the fourth quarter and full year 2023 of approximately $45 million and $176 million Preliminary unaudited net product revenue for the fourth quarter and… Read More
Company well-positioned for further progress and broadening of R&D pipeline Cash resources of approximately $455 million as of December 31, 2023 (unaudited) Expected cash runway, including proceeds from recent private placement, into 2H 2027… Read More
